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Policy Forum
This is the ﬁrst in a series of articles 
on conducting research during complex 
humanitarian emergencies.
T
he United Nations (UN) 
deﬁnes a complex humanitarian 
emergency (CHE) as “a 
humanitarian crisis in a country, 
region, or society where there is 
total or considerable breakdown of 
authority resulting from internal or 
external conﬂict and which requires 
an international response that goes 
beyond the mandate or capacity of any 
single and/or ongoing UN country 
program” [1]. Such emergencies 
require adapted, focused, and 
pragmatic ﬁeld responses to be 
organized within short time frames, 
often under difﬁcult accessibility, 
security, and climate conditions. Over 
the years, operational efﬁciency in the 
ﬁeld has increased thanks to research 
carried out during CHEs. 
Early on following its inception 
in 1971, the international medical 
humanitarian organization Médecins 
Sans Frontières (MSF) conducted its 
medical missions with enthusiasm but 
little standardization, focusing more 
on individual care than on optimized 
public health approaches. Growing 
ﬁeld experience, mainly acquired 
in refugee camps, rapidly led to the 
identiﬁcation of ten major public 
health priorities for CHEs (Box 1). 
Critical analysis of data collected 
by MSF ﬁeld workers generated 
questions about the effectiveness of 
MSF’s operational responses (Box 
2). Recognizing the importance of 
epidemiological surveillance and 
systematic monitoring of CHE activities, 
MSF created its own research center, 
Epicentre, in 1987 with the aim of 
addressing those questions [2]. 
Twenty years later, Epicentre has 
developed into a large team of over 40 
professionals in the headquarters in 
Paris, ofﬁces in Geneva and Brussels, 
and a ﬁeld station in Mbarara, 
Uganda. Through partnerships with 
national and international institutions, 
universities, and research groups, 
Epicentre has gained recognition in 
the ﬁeld of CHE research and, in 1995, 
became a World Health Organization 
(WHO) collaborative center for 
research in epidemiology and control 
of emerging diseases. To this day, 
Epicentre is dedicated to improving 
ﬁeld operations in CHEs. 
In this article, we review Epicentre’s 
20 years of experience conducting 
research during CHEs and show how 
such research has been critical in 
improving ﬁeld response. 
Rapid Assessments and Survey 
Methods
Rapid assessments in CHEs, often 
based on population surveys, help 
guide emergency response by 
measuring mortality rates, prevalence 
of malnutrition, and coverage of basic 
needs (food, water, shelter). 
Over the past 20 years, Epicentre has 
conducted nearly 100 mortality surveys, 
most of them under difﬁcult ﬁeld 
conditions. One illustrative example 
is the survey conducted in July 1994 
among 800,000 Rwandan refugees in 
Goma, Zaïre [3]. Anyone walking along 
the road between Goma and Katale 
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Box 1. Top Priorities to Address 
in Emergencies
•  Rapid assessment of the health status 
of the population
•  Mass vaccination against measles
•  Water supply and implementation of 
sanitary measures
•  Food supply and implementation of 
specialized nutritional rehabilitation 
programs
•  Shelter, site planning, and non-food 
items
•  Curative care based on the use of 
standardized therapeutic protocols, 
using essentials drugs
•  Control and prevention of 
communicable diseases and potential 
epidemics
•  Surveillance and alert
•  Assessment of human resources and 
training and supervision of community 
health workers
•  Coordination of different operational 
partners PLoS Medicine  |  www.plosmedicine.org 0554 April 2008  |  Volume 5  |  Issue 4  |  e89
every morning knew, by looking at 
the bodies piling up along the road, 
that the health situation was extremely 
severe. The survey showed that, in the 
ﬁrst month alone, more than 10% of 
the population had died, 88% from 
diarrhea [4]. The Goma survey, like 
many others, highlights the role of ﬁeld 
epidemiology in properly quantifying 
events, even in the most chaotic 
situations. The data were used for 
programmatic and planning purposes, 
and, in some instances, as advocacy 
material.
Survey sampling schemes used in 
CHEs were originally explored by 
the United States Centers for Disease 
Control and Prevention [5]. Among 
these schemes, cluster sampling (in 
which the population of interest is 
divided into groups, or clusters, and 
a random sample of these clusters is 
selected), initially developed by WHO 
for the estimation of vaccine coverage, 
is often the only option since it is rarely 
possible to survey the entire population 
[6]. When samples of adequate size 
and sufﬁcient number of clusters are 
drawn, estimates are precise enough 
for planning purposes. Research for 
realistic alternatives (such as sampling 
based on global positioning systems) is 
ongoing [7]. 
Estimating population size, which 
is important for needs assessment, 
remains difﬁcult [8,9]. While satellite 
photos could represent a quick and 
valuable alternative to the methods 
currently in use, humanitarian 
organizations operating on foreign soil 
have limited access to such pictures. 
Responding to Infectious Disease 
Outbreaks
In a CHE, overcrowding, inadequate 
shelter, poor water and sanitation, 
collapse of health services, and the 
breakdown of existing infectious 
disease control programs can markedly 
increase the burden of communicable 
diseases and the risk of epidemics. In 
such a context, early detection and 
prompt, well-conducted outbreak 
investigations are essential to guide 
adapted responses. 
Meningococcal meningitis. 
Epidemics of meningococcal 
meningitis constitute a major and 
recurrent burden on public health 
systems in large parts of sub-Saharan 
Africa. An important milestone in 
Epicentre’s research history occurred 
in 1988 when the production of 
oily chloramphenicol, the standard 
treatment for meningococcal 
meningitis, was jeopardized. MSF, with 
others, successfully lobbied to resume 
the drug’s production. Epicentre 
conducted randomized clinical trials 
comparing oily chloramphenicol with 
ampicillin (in 1991) and later with 
ceftriaxone (in 2003) for the treatment 
of meningococcal meningitis. These 
studies were conducted as a reaction 
to nationwide epidemic responses 
in Niger and Mali. Time for logistic 
preparation was necessarily shortened, 
health structures were already 
overwhelmed by the inﬂux of cases of 
meningitis, and some study sites were 
located in remote areas. Through 
the support of national authorities, 
the organization of MSF logistics, 
and the dedication of national and 
international staff involved, the 
scientiﬁc quality of the studies was 
ensured, ethics rules were respected, 
and both clinical trials were published 
[10,11]. 
Measles. Measles remains a major 
potential killer in CHEs. Despite the 
availability of a highly effective, safe, 
and cheap vaccine, protection of 
children against the disease remains 
suboptimal in some areas, notably 
those affected by long-lasting conﬂicts. 
MSF and Epicentre, with the support 
of WHO, recently explored the 
dynamics of measles outbreaks in 
Nigeria, Niger, and Chad to re-examine 
current response strategies [12,13,14]. 
Preliminary results indicate that the 
relatively slow spread and long duration 
of those outbreaks may, in some urban 
settings, leave enough time to plan for 
and conduct reactive mass vaccination 
campaigns [15]. Further analysis is 
needed in rural areas.
Malaria. Malaria can signiﬁcantly 
impact public health services and 
morbidity and mortality during CHEs. 
Epicentre and MSF have conducted 
43 efﬁcacy studies in Africa and Asia 
from 1996 to 2004 involving more 
than 12,000 patients; these studies 
have shown the lack of efﬁcacy of the 
monotherapies that are in widespread 
use [16]. At the same time, Epicentre/
MSF conducted randomized clinical 
trials in Angola, Sierra Leone, and 
Zambia to compare the efﬁcacy of 
several artemisinin-based combination 
therapies (ACTs) with older drugs 
[17,18,19]. These studies showed that 
ACTs were more effective than older 
monotherapies such as chloroquine 
and sulfadoxine-pyrimethamine, which 
helped support changes in national 
protocols to ACTs. Several of these 
trials were conducted in the malaria 
endemic area of Mbarara, Uganda, 
where a research base was set up in 
cooperation with the local university 
hospital. 
Hepatitis E. In 2004, during a large 
hepatitis E outbreak in Darfur, Sudan, 
a study identiﬁed chlorinated surface 
water (compared with non-chlorinated 
water from deep drilling) as a potential 
risk factor for hepatitis E [20]. The 
methods used for the provision of safe 
water were considered insufﬁcient to 
inactivate the hepatitis E virus from 
the chlorinated surface water and 
control this outbreak. MSF is exploring 
alternative methods adapted to CHEs, 
such as deep drilling or ultraviolet 
irradiation. 
Micronutrient Deﬁciencies and 
Malnutrition 
Pellagra. In 1989, an outbreak of 
pellagra (20,000 cases) erupted among 
Mozambican refugees in Malawi. 
Epicentre analysis of the outbreak, 
and World Food Programme log 
books, showed that a shortage of 
groundnuts (the major source of 
niacin) in UN rations was the cause 
Box 2. Examples of Public 
Health Questions Generated in 
the Field of CHEs
•  How accurate are estimates of 
population size provided by rapid 
assessments?
•  What are the best indicators 
to measure the impact of an 
intervention? 
•  What is the validity of the various 
anthropometric indicators used in the 
ﬁeld?
•  Which thresholds should be used 
to deﬁne outbreaks of potentially 
epidemic diseases?
•  How well do commonly used rapid 
diagnostic tests perform under ﬁeld 
conditions?
•  What are the risk factors of death of 
severely malnourished children? 
•  Can reactive mass vaccination 
campaigns help control cholera 
outbreaks in refugee camps?PLoS Medicine  |  www.plosmedicine.org 0555 April 2008  |  Volume 5  |  Issue 4  |  e89
of the outbreak. Groundnut supplies 
were then purchased in South Africa, 
and the outbreak was controlled within 
a few months [21]. This investigation 
illustrates how properly conducted 
studies done in close collaboration 
with local authorities and operational 
partners guided quick decision-making 
and successful outbreak control.
Malnutrition. A high prevalence 
of malnutrition is one of the most 
frequently encountered phenomena 
during CHEs. Simpler methods to 
measure malnutrition at the individual 
and community levels and better 
prevention and treatment protocols can 
reduce the burden of nutritional crises 
and save lives. Using data from nearly 
100 MSF anthropometric surveys, 
Epicentre tested various measurement 
indices as predictors of acute 
malnutrition among children under 
ﬁve years [22,23,24]. Unfortunately, 
we have so far failed to identify a better 
tool than “weight for height,” which is 
difﬁcult to routinely use at primary care 
level. Further research is still needed in 
this area. 
In terms of treatment at community 
level, building on work by André 
Briend and Steve Collins [25,26], 
Epicentre compared malnutrition 
treatment strategies based on home-
based care versus therapeutic feeding 
centers in Maradi, Niger from 2002–
2003 [27]. Results showed similar and 
satisfactory weight gains but lower 
defaulting and death rates with the 
home-based care approach. MSF has 
implemented strategies to address large 
numbers of cases of malnutrition, such 
as in Niger, with data collected and 
analysed by Epicentre. In 2005, nearly 
60,000 children with malnutrition 
in the Maradi region of Niger were 
treated with a ready-to-use therapeutic 
food (Plumpy’nut), resulting in 
recovery rates of about 90% and death 
rates of less than 5% [28]. 
Improving Diagnostic Tools
Diagnostic tools adapted to ﬁeld 
conditions can serve two purposes—
diagnosis of individuals and 
conﬁrmation of an outbreak. Few rapid 
diagnostic tests (RDTs) are designed 
for use in CHEs, and little is known 
about their performance in such a 
context. However, the use of RDTs 
can potentially improve the capacity 
of case detection and the efﬁcacy of 
treatments. Epicentre has tested the 
performance of several RDT kits, which 
are now used in the ﬁeld.
Malaria RDTs must be reliable, 
cheap, and user-friendly, particularly 
if used in CHEs. In addition, the 
performance of the test is maximized 
if the local epidemiology of the disease 
and the immunity of the population are 
taken into account. MSF/Epicentre has 
tested several commercially available 
malaria RDTs under ﬁeld conditions. 
Beyond the classical evaluation of 
the sensitivity and speciﬁcity of the 
tests, our studies focused on practical 
considerations such as ease of use, shelf 
life, and storing conditions [29,30]. 
This approach, although usually 
neglected by researchers, is critical to 
maintaining ﬁeld-oriented research 
in response to questions raised by the 
humanitarian community.
Other RDTs, adapted to the speciﬁc 
conditions of CHEs, are crucially 
needed [31]. In 2003, Epicentre 
conducted a randomized clinical trial 
assessing the sensitivity and speciﬁcity 
of a latex agglutination RDT (Pastorex) 
for Neisseria meningitidis serogroup A 
during a meningitis epidemic in Niger 
[32]. Results from 484 samples showed 
88% sensitivity and 93% speciﬁcity, 
suggesting that this RDT could be 
a favorable alternative to current 
diagnostic tests. Other promising 
tools such as a dipstick for diagnosis 
of Shigella ﬂexneri and Shigella spp. 
[33] and a one-step RDT for cholera 
[34] need to be evaluated in ﬁeld 
conditions. 
Lessons Learned
Finding pragmatic and efﬁcacious 
answers to public health questions 
generated by the ﬁeld has led Epicentre 
research activities over the last 20 years. 
Such an intimate and continuous link 
between ﬁeld operations and applied 
research is unusual in the world of 
humanitarian response to CHEs. The 
nonstop interaction between ﬁeld 
actors and researchers has been key in 
developing an original research agenda 
and conducting successful projects, 
which help improve the quality and 
effectiveness of the operational 
response. This, in turn, enhances the 
capacity of the scientiﬁc community 
and of aid agencies to cope with 
increasingly complex humanitarian 
crises.
Since the creation of Epicentre 
in 1987, a number of operational 
and clinical research projects have 
been conducted. Constraints faced 
in CHEs, too often underestimated, 
make research projects particularly 
challenging. Conditions of their success 
include rigorous technical and logistic 
support, close collaboration with 
local authorities, and fully mobilized 
national and international staff. 
The role of epidemiologists extends 
beyond their traditional scientiﬁc 
research functions to a broader 
range of responsibilities, including 
exchanges with ﬁeld workers to 
help generate research ideas and 
reconciliation of rigorous methods 
with local constraints. External ethical 
review, written informed consent, and 
involvement of the local community are 
some of the systematic mechanisms that 
helped Epicentre carry out research 
projects that respect the principles of 
ethical human subjects research. 
The results of the research 
conducted by MSF/Epicentre and 
others over the last two decades have 
shown the limitations of current 
therapeutic and preventive resources 
for most of the diseases prevalent in 
developing countries. The Drugs for 
Neglected Diseases Initiative (DNDi), 
initially promoted and funded by MSF 
in 2003, focuses on developing new 
drugs or formulations for patients 
suffering from the world’s most 
neglected diseases [35]. Today, 22 
DNDi research and development 
projects are under way, with the goal of 
developing six to eight new treatments 
in the next ten years [36]. Some 
projects have been implemented within 
MSF CHE programs, with Epicentre 
providing research and data analysis 
support. 
Next Steps
Looking towards the future, Epicentre 
continues to address unanswered 
questions in the ﬁeld epidemiology 
of CHEs. Among these, the aim is 
to continue to improve the control 
of infectious diseases and patient 
management, including easy-to-use and 
cheap alternative therapeutic regimens 
and preventive strategies. Conducting 
high-quality research in CHEs means 
testing new techniques in remote 
areas, while taking into consideration 
all usual aspects of logistics and 
ethics. Improved survey methods and 
surveillance systems are continuing 
challenges for the future. Some under-PLoS Medicine  |  www.plosmedicine.org 0556 April 2008  |  Volume 5  |  Issue 4  |  e89
researched areas should be further 
explored. The ultimate goal remains to 
address questions aimed at signiﬁcantly 




Additional studies by Epicentre/MSF on 
rapid assessments and survey methods (list 
1), nutrition (list 2), infectious disease 
control (list 3), and epidemics, malaria, and 
diagnostic tools (list 4)
Found at doi:10.1371/journal.
pmed.0050089.sd001 (58 KB DOC)
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